Banana Youssef, Bashir Husam, Boukabous Sara, Haddiya Intissar, Bentata Yassamine, Rezziki Abdellah, Benzirar Adnane, El Mahi Omar
Departments of Vascular Surgery.
Nephrology - Dialysis and Kidney Transplantation, Mohammed VI University Hospital of Oujda.
Ann Med Surg (Lond). 2023 Mar 24;85(3):485-487. doi: 10.1097/MS9.0000000000000152. eCollection 2023 Mar.
Coronavirus disease 2019 (COVID-19) is a worldwide pandemic systemic infection that is responsible for serious coagulopathies similar to disseminated intravascular coagulation.
The authors report the case of a COVID-19 patient who presented with phlegmasia cerulea dolens (PCD) of the left lower limb, so he benefited from aponeurotomies of the internal and anterolateral muscular compartments.
The severe acute respiratory syndrome coronavirus 2 involves an inflammatory process in thrombotic events in COVID-19 patients, including a cytokine storm. PCD evolves in three semiological phases: venous stasis, weakening of the pulses, and the constitution of major ischemia. In the literature, the authors find many reports that have been published regarding increased thrombus formation in COVID-19 patients; these include DVT formation, pulmonary embolism, and stroke. Nevertheless, publications concerning PCD in COVID-19 patients remain rare.
Although the severe acute respiratory syndrome coronavirus 2 remains a thrombogenic pathology, systematic anticoagulation is the subject of hypothesis. Hence the importance of regular monitoring of markers of vascular thrombosis.
2019冠状病毒病（COVID-19）是一种全球性大流行的全身性感染，可导致类似于弥散性血管内凝血的严重凝血病。
作者报告了一例COVID-19患者，该患者出现左下肢股青肿（PCD），因此接受了内肌和前外侧肌间隔的腱膜切开术。
严重急性呼吸综合征冠状病毒2在COVID-19患者的血栓形成事件中涉及炎症过程，包括细胞因子风暴。股青肿有三个症状阶段：静脉淤滞、脉搏减弱和严重缺血形成。在文献中，作者发现许多关于COVID-19患者血栓形成增加的报道；这些包括深静脉血栓形成、肺栓塞和中风。然而，关于COVID-19患者股青肿的出版物仍然很少。
尽管严重急性呼吸综合征冠状病毒2仍然是一种血栓形成性疾病，但系统性抗凝仍是一个假设的主题。因此，定期监测血管血栓形成标志物非常重要。
